S&P 500   4,975.51
DOW   38,563.80
QQQ   427.32
Higher VIX just made Realty Income’s 6% dividend better
Is Gold Really Boring? (Ad)
Super Micro Computer: Overbought, undervalued or mispriced?
Booking stock is the discounted growth story in travel stocks
Is Gold Really Boring? (Ad)
3 E-VTOL stocks: Which ones can fly higher in 2024?
Capital One's bid for Discover carries expectation that Americans won't slow credit card use
Is Gold Really Boring? (Ad)
Walmart’s uptrend is intact; buy it when it dips
Michael Burry just went all in on Alibaba stock, one value bet
S&P 500   4,975.51
DOW   38,563.80
QQQ   427.32
Higher VIX just made Realty Income’s 6% dividend better
Is Gold Really Boring? (Ad)
Super Micro Computer: Overbought, undervalued or mispriced?
Booking stock is the discounted growth story in travel stocks
Is Gold Really Boring? (Ad)
3 E-VTOL stocks: Which ones can fly higher in 2024?
Capital One's bid for Discover carries expectation that Americans won't slow credit card use
Is Gold Really Boring? (Ad)
Walmart’s uptrend is intact; buy it when it dips
Michael Burry just went all in on Alibaba stock, one value bet
S&P 500   4,975.51
DOW   38,563.80
QQQ   427.32
Higher VIX just made Realty Income’s 6% dividend better
Is Gold Really Boring? (Ad)
Super Micro Computer: Overbought, undervalued or mispriced?
Booking stock is the discounted growth story in travel stocks
Is Gold Really Boring? (Ad)
3 E-VTOL stocks: Which ones can fly higher in 2024?
Capital One's bid for Discover carries expectation that Americans won't slow credit card use
Is Gold Really Boring? (Ad)
Walmart’s uptrend is intact; buy it when it dips
Michael Burry just went all in on Alibaba stock, one value bet
S&P 500   4,975.51
DOW   38,563.80
QQQ   427.32
Higher VIX just made Realty Income’s 6% dividend better
Is Gold Really Boring? (Ad)
Super Micro Computer: Overbought, undervalued or mispriced?
Booking stock is the discounted growth story in travel stocks
Is Gold Really Boring? (Ad)
3 E-VTOL stocks: Which ones can fly higher in 2024?
Capital One's bid for Discover carries expectation that Americans won't slow credit card use
Is Gold Really Boring? (Ad)
Walmart’s uptrend is intact; buy it when it dips
Michael Burry just went all in on Alibaba stock, one value bet

Relay Therapeutics (RLAY) Short Interest Ratio & Short Volume

$10.71
-0.13 (-1.20%)
(As of 02/20/2024 ET)

Relay Therapeutics Short Interest Data

Current Short Volume
9,450,000 shares
Previous Short Volume
11,290,000 shares
Change Vs. Previous Month
-16.30%
Dollar Volume Sold Short
$87.41 million
Short Interest Ratio / Days to Cover
9.5
Last Record Date
January 31, 2024
Outstanding Shares
127,460,000 shares
Float Size
86,260,000 shares
Short Percent of Float
10.96%
Today's Trading Volume
811,665 shares
Average Trading Volume
1,025,033 shares
Today's Volume Vs. Average
79%
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling Relay Therapeutics ?

Sign up to receive the latest short interest report for Relay Therapeutics and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

RLAY Short Interest Over Time

RLAY Days to Cover Over Time

RLAY Percentage of Float Shorted Over Time


Relay Therapeutics Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
1/31/20249,450,000 shares $87.41 million -16.3%11.0%9.5 $9.25
1/15/202411,290,000 shares $124.19 million -6.0%13.1%10.3 $11.00
12/31/202312,010,000 shares $132.23 million -12.3%14.1%10.4 $11.01
12/15/202313,700,000 shares $138.92 million -6.4%16.1%11.5 $10.14
11/30/202314,630,000 shares $115.72 million -0.1%17.3%12.1 $7.91
11/15/202314,640,000 shares $125.17 million +1.5%17.3%12.7 $8.55
10/31/202314,430,000 shares $95.24 million +4.8%16.9%12.9 $6.60
10/15/202313,770,000 shares $106.58 million -29.0%16.3%13.5 $7.74
9/30/202319,400,000 shares $163.15 million -3.4%22.9%19.9 $8.41
9/15/202320,080,000 shares $188.15 million +1.0%23.7%21 $9.37
8/31/202319,890,000 shares $203.28 million -3.9%23.5%19.1 $10.22
8/15/202320,700,000 shares $219.83 million +5.5%24.5%18.3 $10.62
7/31/202319,630,000 shares $247.34 million -1.1%23.3%16.4 $12.60
7/15/202319,840,000 shares $242.64 million -3.1%23.8%14.7 $12.23
6/30/202320,480,000 shares $257.23 million -2.9%24.6%12.1 $12.56
6/15/202321,080,000 shares $269.61 million -0.4%25.3%12.3 $12.79
5/31/202321,160,000 shares $235.72 million -1.5%25.4%13.1 $11.14
5/15/202321,480,000 shares $221.03 million +8.5%25.8%13.6 $10.29
4/30/202319,800,000 shares $225.13 million +1.4%23.4%13 $11.37
4/15/202319,530,000 shares $340.60 million +3.3%23.1%13.3 $17.44
3/31/202318,910,000 shares $311.45 million +5.5%22.4%15.4 $16.47
3/15/202317,930,000 shares $295.85 million +0.8%21.3%13.8 $16.50
2/28/202317,780,000 shares $287.15 million +3.0%21.1%13 $16.15
2/15/202317,270,000 shares $317.25 million -0.6%20.6%12.9 $18.37
1/31/202317,380,000 shares $372.97 million -6.9%20.7%13 $21.46
1/15/202318,660,000 shares $387.57 million +10.5%22.2%14.7 $20.77
12/30/202216,890,000 shares $252.34 million +25.8%20.0%13.8 $14.94
12/15/202213,430,000 shares $230.59 million +7.5%15.9%12.2 $17.17
11/30/202212,490,000 shares $232.06 million -4.3%14.8%11.1 $18.58
11/15/202213,050,000 shares $258.39 million -3.1%15.4%10.5 $19.80
10/31/202213,460,000 shares $299.08 million +3.1%16.5%10.9 $22.22
10/15/202213,060,000 shares $254.80 million +7.2%16.1%10.4 $19.51
9/30/202212,180,000 shares $272.47 million +4.0%15.0%10.2 $22.37
9/15/202211,710,000 shares $293.69 million -25.0%15.9%9.2 $25.08
8/31/202215,620,000 shares $358.79 million -15.2%21.2%13.4 $22.97
8/15/202218,420,000 shares $386.27 million -1.8%25.1%18.1 $20.97
7/31/202218,760,000 shares $356.82 million -1.4%25.6%17.4 $19.02
7/15/202219,020,000 shares $368.99 million -6.8%26.0%17.9 $19.40
6/30/202220,410,000 shares $341.87 million +11.2%27.9%20.2 $16.75
6/15/202218,360,000 shares $263.10 million +2.5%25.1%19.2 $14.33













RLAY Short Interest - Frequently Asked Questions

What is Relay Therapeutics' current short interest?

Short interest is the volume of Relay Therapeutics shares that have been sold short but have not yet been closed out or covered. As of January 31st, traders have sold 9,450,000 shares of RLAY short. 10.96% of Relay Therapeutics' shares are currently sold short. Learn More on Relay Therapeutics' current short interest.

What is a good short interest ratio for Relay Therapeutics?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. RLAY shares currently have a short interest ratio of 10.0. Learn More on Relay Therapeutics's short interest ratio.

Which institutional investors are shorting Relay Therapeutics?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Relay Therapeutics: Citadel Advisors LLC, Concourse Financial Group Securities Inc., and Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

What is a good short interest percentage for Relay Therapeutics?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 10.96% of Relay Therapeutics' floating shares are currently sold short.

Is Relay Therapeutics' short interest increasing or decreasing?

Relay Therapeutics saw a decrease in short interest in the month of January. As of January 31st, there was short interest totaling 9,450,000 shares, a decrease of 16.3% from the previous total of 11,290,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Relay Therapeutics' float size?

Relay Therapeutics currently has issued a total of 127,460,000 shares. Some of Relay Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Relay Therapeutics currently has a public float of 86,260,000 shares.

How does Relay Therapeutics' short interest compare to its competitors?

10.96% of Relay Therapeutics' shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Relay Therapeutics: 4D Molecular Therapeutics, Inc. (8.98%), ADMA Biologics, Inc. (3.03%), Scholar Rock Holding Co. (15.81%), Adaptimmune Therapeutics plc (0.47%), Vir Biotechnology, Inc. (6.57%), Autolus Therapeutics plc (1.69%), Sana Biotechnology, Inc. (21.46%), Cabaletta Bio, Inc. (14.91%), Tarsus Pharmaceuticals, Inc. (16.40%), Immatics (9.40%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($4.48 billion), General Motors ($3.85 billion), Charter Communications, Inc. ($3.38 billion), Occidental Petroleum Co. ($3.00 billion), Super Micro Computer, Inc. ($2.66 billion), Tractor Supply ($2.37 billion), Coinbase Global, Inc. ($2.25 billion), Moderna, Inc. ($2.11 billion), Royal Caribbean Cruises Ltd. ($2.06 billion), and Floor & Decor Holdings, Inc. ($1.67 billion). View all of the most shorted stocks.

What does it mean to sell short Relay Therapeutics stock?

Short selling RLAY is an investing strategy that aims to generate trading profit from Relay Therapeutics as its price is falling. RLAY shares are trading down $0.13 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Relay Therapeutics?

A short squeeze for Relay Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of RLAY, which in turn drives the price of the stock up even further.

How often is Relay Therapeutics' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including RLAY, twice per month. The most recent reporting period available is January, 31 2024.



More Short Interest Resources from MarketBeat

This page (NASDAQ:RLAY) was last updated on 2/21/2024 by MarketBeat.com Staff